ArticleImmunity, inflammation and disease2026
Identification of Discriminatory Factors and Construction of a Nomogram for Differentiating IgG4-RD and DLBCL.
Article in Immunity, inflammation and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Identification of Discriminatory Factors and Construction of a Nomogram for Differentiating IgG4-RD and DLBCL.Immunity, inflammation and disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveTo determine clinically useful indicators that distinguish IgG4-related disease (IgG4-RD) from diffuse large B-cell lymphoma (DLBCL) and to construct a predictive model that may assist early identification.
methodsWe retrospectively analyzed 19 patients with IgG4-RD and 37 with DLBCL who presented with lymphadenopathy and received treatment at the Affiliated Hospital of Xuzhou Medical University between January 2012 and October 2025. The distribution of continuous variables was checked before group comparisons. Data with an approximately normal distribution are expressed as mean ± standard deviation (mean ± SD) and were compared by independent-samples t-tests; skewed data are reported as median (interquartile range [IQR]) and were compared by the Mann-Whitney U test. Categorical variables are presented as counts and percentages (%) and were compared using the χ
resultsMultivariable logistic regression retained lymphocyte count, serum total protein, and prothrombin time (PT) as independent predictive factors. The model yielded an area under the receiver operating characteristic curve (AUC) of 0.91 (95% confidence interval [CI]: 0.82-0.99). Its calibration curve had a mean absolute error of 0.032. Across threshold probabilities from 0.2 to 1.0, decision curve analysis indicated greater net benefit than the "treat-all" and "treat-none" approaches.
conclusionIn this cohort, the predictive model showed potential to assist differentiation between IgG4-RD and DLBCL. Because the study was retrospective, single-center, and based on a limited sample, these findings should be regarded as preliminary and require confirmation in larger independent cohorts before clinical use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.